IPO fundraising doubles to ₹51,365 cr in H1 FY25, QIP triples to ₹66,225 cr
The primary market saw a surge in momentum in the last two months, with 22 out of the 40 IPOs coming in August and September.
The primary market saw a surge in momentum in the last two months, with 22 out of the 40 IPOs coming in August and September.
10.15 crore equity shares of Indian Bank, allotted to qualified institutional buyers (QIBs), got listed on the stock exchanges today.
Each of the warrants is convertible into an equivalent number of equity shares in 18 months from the date of allotment
The home appliances company proposes to raise ₹1,000 crore via qualified institutional placement (QIP) of shares at floor price of ₹784.55 apiece.
The wind turbine manufacturer will raise up to ₹2,000 crore through qualified institutional placement.
The real estate investment trust will use proceeds to fund the acquisition of 50% stake in two large commercial assets.
Orchid Pharma stock trades 12% lower than its 52-week high of ₹463.05, while it has surged 56% against its 52-week low of ₹260.20.